Intravenous iron supplementation in the anaemia of renal and cardiac failure--a double-edged sword?
about
Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy.Infection risk with bolus versus maintenance iron supplementation in hemodialysis patientsEffect of Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor.Anemia in heart failure: pathophysiologic insights and treatment options.Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration.
P2860
Intravenous iron supplementation in the anaemia of renal and cardiac failure--a double-edged sword?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Intravenous iron supplementati ...... failure--a double-edged sword?
@ast
Intravenous iron supplementati ...... failure--a double-edged sword?
@en
type
label
Intravenous iron supplementati ...... failure--a double-edged sword?
@ast
Intravenous iron supplementati ...... failure--a double-edged sword?
@en
prefLabel
Intravenous iron supplementati ...... failure--a double-edged sword?
@ast
Intravenous iron supplementati ...... failure--a double-edged sword?
@en
P356
P1476
Intravenous iron supplementati ...... failure--a double-edged sword?
@en
P2093
Itzchak Slotki
P304
P356
10.1093/NDT/GFH1102
P407
P478
20 Suppl 7
P577
2005-07-01T00:00:00Z